Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: Clinical features and therapeutic response

Journal of Clinical Neuromuscular Disease

Volumn 13, Issue 1, 2011, Pages 46-52

  Mittal, Manoj Kumar ^a   Barohn, Richard J ^a   Pasnoor, Mamatha ^a   McVey, April ^a   Herbelin, Laura ^a   Whittaker, Thomas ^a   Dimachkie, Mazen ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

acute management; diplopia; neuro ophthalmology clinic; ocular myasthenia gravis; ptosis

Indexed keywords

CHOLINERGIC RECEPTOR; EDROPHONIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PYRIDOSTIGMINE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BLEPHAROSPASM; CRANIAL NERVE PARALYSIS; DIPLOPIA; ELECTROMYOGRAPHY; ENDOCRINE OPHTHALMOPATHY; FATIGUE; FEMALE; FOLLOW UP; GAZE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; MYOPATHY; NERVE STIMULATION; NEUROOPHTHALMOLOGY; OCULAR MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PTOSIS; SARCOIDOSIS; SENSITIVITY AND SENSIBILITY; SLEEP APNEA SYNDROME; TRANSFORMED MYASTHENIA GRAVIS; VERTICAL STRABISMUS;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DIPLOPIA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; OCULOMOTOR MUSCLES; OUTPATIENT CLINICS, HOSPITAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052466473     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e31821c5634     Document Type: Article

References (18)

1. Van Stavern GP, Bhatt A, Haviland J, et al. A prospective study assessing the utility of Cogans lid twitch sign in patients with isolated unilateral or bilateral ptosis. J Neurol Sci. 2007;256:84-85 (Pubitemid 46560623)
2. Barohn RJ. Standards of measurements in myasthenia gravis. Ann N Y Acad Sci. 2003;998:432-439 (Pubitemid 37194195)
3. Monsul NT, Patwa HS, Knorr AM, et al. The effect of prednisone on the progression from ocular to generalized myasthenia gravis. J Neurol Sci. 2004; 217:131-133 (Pubitemid 38056545)
4. Papapetropoulos TH, Ellul J, Tsibri E. Development of generalized myasthenia gravis in patients with ocular myasthenia gravis. Arch Neurol. 2003;60: 1491-1492
5. Mee JMBBS, Paine MMBBS, Byrne EMDDSC, et al. Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis. J Neuroophthalmol. 2003;23:251-255
6. Kupersmith MJ, Latkany R, Homel P. Development of generalized disease at 2 years in patients with ocular myasthenia gravis. Arch Neurol. 2003;60: 243-248 (Pubitemid 36193969)
7. Sommer N, Sigg B, Melms A, et al. Ocular myasthenia gravis: response to long-term immunosuppressive treatment. J Neurol Neurosurg Psychiatry. 1997;62: 156-162 (Pubitemid 27090934)
8. Grob D, Arsura EL, Brunner NG, et al. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci. 1987;505:472-499
9. Luchanok U, Kaminski HJ. Ocular myasthenia: diagnostic and treatment recommendations and the evidence base. Curr Opin Neurol. 2008;21:8-15
10. Nicholson GA, McLeod JG, Griffiths LR. Comparison of diagnostic tests in myasthenia gravis. Clin Exp Neurol. 1983;19:45-49
11. Chatzistefanou KI, Kouris T, Iliakis E, et al. The ice pack test in the differential diagnosis of myasthenic diplopia. Ophthalmology. 2009;116:2236-2243
12. Kupersmith MJ. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up. J Neurol. 2009;256:1314-1320
13. Benatar M, Kaminski HJ. Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;68:2144-2149 (Pubitemid 46912135)
14. Benatar M, Kaminski H. Medical and surgical treatment for ocular myasthenia. Cochrane Database Syst Rev. 2006;2:CD005081
15. Kupersmith MJ, Ying G. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment. Br J Ophthalmol. 2005;89:1330-1334 (Pubitemid 41638875)
16. Kupersmith MJ. Does early immunotherapy reduce the conversion of ocular myasthenia gravis to generalized myasthenia gravis? J Neuroophthalmol. 2003;23:249-250 (Pubitemid 37532135)
17. Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord. 2006;16: 459-467 (Pubitemid 44094102)
18. Padua L, Stalberg E, LoMonaco M, et al. SFEMG in ocular myasthenia gravis diagnosis. Clin Neurophysiol. 2000;111:1203-1207 (Pubitemid 30394486)